BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Authors
» James Etheridge
James Etheridge
Articles
ARTICLES
NicOx Grants AstraZeneca Exclusive License For Japan
Oct. 1, 2002
By
James Etheridge
Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders
Sep. 25, 2002
By
James Etheridge
Genset Shareholders Accept Bid From Serono; Integration Begins
Sep. 25, 2002
By
James Etheridge
Genset Shareholders Accept Bid From Serono; Integration Begins
Sep. 25, 2002
By
James Etheridge
Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders
Sep. 25, 2002
By
James Etheridge
Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor
Sep. 18, 2002
By
James Etheridge
French Researchers Discover Genetic Origin For Colon Cancer
Sep. 18, 2002
By
James Etheridge
French Researchers Discover Genetic Origin For Colon Cancer
Sep. 18, 2002
By
James Etheridge
Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor
Sep. 18, 2002
By
James Etheridge
With New Premises, Tropos Launches €15M Funding Round
Sep. 11, 2002
By
James Etheridge
View All Articles by James Etheridge
